Sunpointe’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.8M Sell
15,530
-872
-5% -$203K 1.24% 19
2025
Q4
$3.39M Sell
16,402
-729
-4% -$144K 1.13% 24
2025
Q3
$3.18M Buy
17,131
+703
+4% +$120K 1.15% 21
2025
Q2
$2.51M Buy
16,428
+2,257
+16% +$347K 1% 23
2025
Q1
$2.35M Sell
14,171
-1,127
-7% -$176K 1.25% 21
2024
Q4
$2.21M Buy
15,298
+10,941
+251% +$1.7M 1.11% 24
2024
Q3
$706K Buy
4,357
+876
+25% +$140K 0.58% 44
2024
Q2
$509K Sell
3,481
-5
-0.1% -$744 0.33% 61
2024
Q1
$551K Buy
3,486
+315
+10% +$50.1K 0.61% 44
2023
Q4
$497K Buy
+3,171
New +$486K 0.63% 43

Other funds holding JNJ

Sunpointe's JNJ Position: Q1 2026 in Review

Sunpointe reduced its Johnson & Johnson (JNJ) stake by 5.3% in Q1 2026, selling an estimated $203K and leaving 15,530 shares worth $3.8M. The position accounts for 1.24% of the portfolio, ranked #19.

Sunpointe first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sunpointe held 15,530 shares of Johnson & Johnson worth $3.8M as of Q1 2026.
  • Sunpointe sold 872 Johnson & Johnson shares in Q1 2026, an estimated $203K.
  • Johnson & Johnson made up 1.24% of Sunpointe's portfolio in Q1 2026, its #19 holding.
  • Sunpointe first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sunpointe's 13F filing for Q1 2026, filed 21 Apr 2026.